Mustang Bio Inc (MBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,258 | 17,266 | 18,984 | 12,657 | 14,231 |
| Receivables | 217 | 217 | 217 | 217 | 467 |
| TOTAL | $16,582 | $17,593 | $19,361 | $13,046 | $14,909 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $16,582 | $17,593 | $19,361 | $13,046 | $14,909 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,315 | 5,411 | 6,911 | 7,500 | 8,337 |
| Accrued Expenses | 2,521 | 2,503 | 2,529 | 2,504 | 2,813 |
| TOTAL | $7,836 | $7,914 | $9,440 | $10,004 | $11,150 |
| Non-Current Liabilities | |||||
| TOTAL | $150 | $150 | $150 | $150 | $150 |
| Total Liabilities | $7,986 | $8,064 | $9,590 | $10,154 | $11,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,578 | 7,577 | 7,299 | 7,240 | 4,378 |
| Common Shares | 1 | 274 | 1 | N/A | 0 |
| Retained earnings | -399,599 | -398,644 | -398,106 | -397,638 | -396,876 |
| TOTAL | $8,596 | $9,529 | $9,771 | $2,892 | $3,609 |
| Total Liabilities And Equity | $16,582 | $17,593 | $19,361 | $13,046 | $14,909 |